Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | CHEK1 |
Variant | D336* |
Impact List | nonsense |
Protein Effect | gain of function |
Gene Variant Descriptions | CHEK1 D336* results in a premature truncation of the Chek1 protein at amino acid 336 of 476 (UniProt.org). D336* confers a gain of function to the Chek1 protein as demonstrated by increased autophosphorylation and phosphorylation of Cdc25c in in vitro assays, and delayed cell cycle progression and impaired inactivating phosphorylation during mitosis in culture (PMID: 14681223). |
Associated Drug Resistance | |
Category Variants Paths |
CHEK1 mutant CHEK1 act mut CHEK1 D336* |
Transcript | NM_001114121.2 |
gDNA | chr11:g.125644173_125644175delGATinsTAA |
cDNA | c.1006_1008delGATinsTAA |
Protein | p.D336* |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001244846.1 | chr11:g.125644173_125644175delGATinsTAA | c.1006_1008delGATinsTAA | p.D336* | RefSeq | GRCh38/hg38 |
NM_001274 | chr11:g.125644173_125644175delGATinsTAA | c.1006_1008delGATinsTAA | p.D336* | RefSeq | GRCh38/hg38 |
NM_001274.5 | chr11:g.125644173_125644175delGATinsTAA | c.1006_1008delGATinsTAA | p.D336* | RefSeq | GRCh38/hg38 |
NM_001114122.2 | chr11:g.125644173_125644175delGATinsTAA | c.1006_1008delGATinsTAA | p.D336* | RefSeq | GRCh38/hg38 |
NM_001114121.2 | chr11:g.125644173_125644175delGATinsTAA | c.1006_1008delGATinsTAA | p.D336* | RefSeq | GRCh38/hg38 |
XM_024448337.2 | chr11:g.125644173_125644175delGATinsTAA | c.1006_1008delGATinsTAA | p.D336* | RefSeq | GRCh38/hg38 |
XM_017017146.2 | chr11:g.125644173_125644175delGATinsTAA | c.1006_1008delGATinsTAA | p.D336* | RefSeq | GRCh38/hg38 |
NM_001114121 | chr11:g.125644173_125644175delGATinsTAA | c.1006_1008delGATinsTAA | p.D336* | RefSeq | GRCh38/hg38 |
XM_017017146 | chr11:g.125644173_125644175delGATinsTAA | c.1006_1008delGATinsTAA | p.D336* | RefSeq | GRCh38/hg38 |
NM_001274.5 | chr11:g.125644173_125644175delGATinsTAA | c.1006_1008delGATinsTAA | p.D336* | RefSeq | GRCh38/hg38 |
NM_001114122 | chr11:g.125644173_125644175delGATinsTAA | c.1006_1008delGATinsTAA | p.D336* | RefSeq | GRCh38/hg38 |
XM_047426311.1 | chr11:g.125644173_125644175delGATinsTAA | c.1006_1008delGATinsTAA | p.D336* | RefSeq | GRCh38/hg38 |
XM_024448337.1 | chr11:g.125644173_125644175delGATinsTAA | c.1006_1008delGATinsTAA | p.D336* | RefSeq | GRCh38/hg38 |
NM_001114122.3 | chr11:g.125644173_125644175delGATinsTAA | c.1006_1008delGATinsTAA | p.D336* | RefSeq | GRCh38/hg38 |
NM_001244846 | chr11:g.125644173_125644175delGATinsTAA | c.1006_1008delGATinsTAA | p.D336* | RefSeq | GRCh38/hg38 |
NM_001244846.1 | chr11:g.125644173_125644175delGATinsTAA | c.1006_1008delGATinsTAA | p.D336* | RefSeq | GRCh38/hg38 |
NM_001114121.2 | chr11:g.125644173_125644175delGATinsTAA | c.1006_1008delGATinsTAA | p.D336* | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|